Mid-term follow-up and outcomes of patients with prosthetic heart valves: a single-centre experience.
Echocardiography
Patient outcomes
Prosthetic heart valves
Journal
Echo research and practice
ISSN: 2055-0464
Titre abrégé: Echo Res Pract
Pays: England
ID NLM: 101664713
Informations de publication
Date de publication:
06 Jun 2022
06 Jun 2022
Historique:
received:
14
10
2021
accepted:
21
03
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Patients with prosthetic heart valves (PHV) require long-term follow-up, usually within a physiologist led heart valve surveillance clinic. These clinics are well established providing safe and effective patient care. The disruption of the COVID-19 pandemic on services has increased wait times thus we undertook a service evaluation to better understand the patients currently within the service and PHV related complications. A clinical service evaluation of the heart valve surveillance clinic was undertaken to assess patient demographics, rates of complications and patient outcomes in patients who had undergone a PHV intervention at our institute between 2010 and 2020. A total of 294 patients (mean age at time of PHV intervention: 71 ± 12 years, 68.7% male) were included in this service evaluation. Follow-up was 5.9 ± 2.7 years (range: 10 years). 37.1% underwent baseline transthoracic echo (TTE) assessment and 83% underwent annual TTE follow-up. Significant valve related complications were reported in 20 (6.8%) patients. Complications included a change in patient functional status secondary to significant PHV regurgitation (0.3%) or stenosis (0.3%), PHV thrombosis (0.3%) or infective endocarditis (3.7%). Significant valve related complications resulted in ten hospital admission (3.4%), two re-do interventions (0.6%), and four deaths (1.3%). This service evaluation highlights the large number of patients requiring ongoing surveillance. Only a small proportion of patients develop significant PHV related complications resulting in a low incidence of re-do interventions and deaths.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with prosthetic heart valves (PHV) require long-term follow-up, usually within a physiologist led heart valve surveillance clinic. These clinics are well established providing safe and effective patient care. The disruption of the COVID-19 pandemic on services has increased wait times thus we undertook a service evaluation to better understand the patients currently within the service and PHV related complications.
METHODS
METHODS
A clinical service evaluation of the heart valve surveillance clinic was undertaken to assess patient demographics, rates of complications and patient outcomes in patients who had undergone a PHV intervention at our institute between 2010 and 2020.
RESULTS
RESULTS
A total of 294 patients (mean age at time of PHV intervention: 71 ± 12 years, 68.7% male) were included in this service evaluation. Follow-up was 5.9 ± 2.7 years (range: 10 years). 37.1% underwent baseline transthoracic echo (TTE) assessment and 83% underwent annual TTE follow-up. Significant valve related complications were reported in 20 (6.8%) patients. Complications included a change in patient functional status secondary to significant PHV regurgitation (0.3%) or stenosis (0.3%), PHV thrombosis (0.3%) or infective endocarditis (3.7%). Significant valve related complications resulted in ten hospital admission (3.4%), two re-do interventions (0.6%), and four deaths (1.3%).
CONCLUSIONS
CONCLUSIONS
This service evaluation highlights the large number of patients requiring ongoing surveillance. Only a small proportion of patients develop significant PHV related complications resulting in a low incidence of re-do interventions and deaths.
Identifiants
pubmed: 35659315
doi: 10.1186/s44156-022-00001-w
pii: 10.1186/s44156-022-00001-w
pmc: PMC9167640
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1Informations de copyright
© 2022. The Author(s).
Références
Echo Res Pract. 2018 Sep;5(3):113-119
pubmed: 29976783
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
J Am Soc Echocardiogr. 2009 Sep;22(9):975-1014; quiz 1082-4
pubmed: 19733789
Echo Res Pract. 2019 Dec 1;6(4):E1-E2
pubmed: 31725409
Open Heart. 2020 Apr 20;7(1):e001262
pubmed: 32399252
Echo Res Pract. 2019 Mar 1;6(1):G9-G15
pubmed: 30763277
Curr Probl Cardiol. 2000 Feb;25(2):73-154
pubmed: 10709140
Prog Cardiovasc Dis. 2008 Jan-Feb;50(4):274-81
pubmed: 18156006